Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)
The objective of this study is to evaluate the safety and efficacy of two investigational drugs in lowering blood pressure and body weight in patients with hypertension (high blood pressure).
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of MK0736 and MK0916 in Hypertensive Patients|
- Reduction in blood pressure, safety and tolerability
- Waist circumference, dose comparison
|Study Start Date:||November 2005|
|Study Completion Date:||January 2007|
|Primary Completion Date:||January 2007 (Final data collection date for primary outcome measure)|